What is the rate of Treatment Related Adverse Events with CTCAE >= 3 at the RD for AZD0022 monotherapy in NCT06599502?
2
125Ṁ73Dec 31
56%
<= 10%
12%
<= 20% & >10%
12%
<= 30% & >20%
10%
<= 60% & >30%
10%
(<= 100% & >60%) OR termination due to high toxicity
The question is resolved based on data in the last publication related to this clinical trial. The question does not resolve if no results are reported within 6 months after the official end date 2028-01-20. If the trial is ended due to high toxicity, the last option is selected.
This question is managed and resolved by Manifold.
Get 
1,000 to start trading!
1,000Sort by:
Buying <= 10% based on previous results from Novartis https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.9007